Lakewood Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,217
Closed -$340K 121
2024
Q4
$340K Hold
3,217
0.23% 85
2024
Q3
$347K Buy
3,217
+1
+0% +$109 0.24% 80
2024
Q2
$349K Hold
3,216
0.24% 79
2024
Q1
$424K Buy
3,216
+777
+32% +$97.1K 0.29% 74
2023
Q4
$297K Sell
2,439
-398
-14% -$44.4K 0.23% 78
2023
Q3
$318K Buy
2,837
+52
+2% +$6.6K 0.26% 80
2023
Q2
$406K Buy
2,785
+1
+0% +$136 0.32% 69
2023
Q1
$360K Buy
2,784
+2
+0.1% +$251 0.3% 73
2022
Q4
$355K Buy
+2,782
New +$323K 0.29% 71

Other funds holding ZBH

Lakewood Asset Management's ZBH Position: Q1 2025 in Review

Lakewood Asset Management sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 3,217 shares — an estimated $340K sold.

Lakewood Asset Management first reported a position in ZBH in Q4 2022 and held it in 9 quarters. The position peaked at $424K in Q1 2024. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • Lakewood Asset Management reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • Lakewood Asset Management sold 3,217 Zimmer Biomet shares in Q1 2025, an estimated $340K.
  • Lakewood Asset Management first reported a position in Zimmer Biomet in Q4 2022 and held it in 9 quarters.
  • Lakewood Asset Management's Zimmer Biomet position peaked at $424K in Q1 2024.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Lakewood Asset Management's 13F filing for Q1 2025, filed 24 Apr 2025.